A New Era Begins: Damon Brain Becomes First-Ever CEO at Duncan & Toplis
New leadership and structure to underpin next stage of ambitious group-wide growth strategy GRANTHAM, England–(BUSINESS WIRE)–Marking the start of an... Read more.
Shippeo Named a Leader in the 2024 Gartner® Magic Quadrant™ for Real-Time Transportation Visibility Platforms, Announces Record Growth in North America and APAC
Shippeo experiences impressive growth and market momentum, with 153% year over year growth in North America Focus on high data quality, platform experience, and... Read more.
Proofpoint Named an Overall Leader in KuppingerCole Leadership Compass for Email Security
Proofpoint’s Threat Protection platform achieves a “Strong Positive” rating in all categories and is recognized as a Product Leader, Innovation... Read more.
Countdown to the Finals of the ASC24 Student Supercomputer Challenge!
BEIJING–(BUSINESS WIRE)–#ASC–The 2024 ASC Student Supercomputer Challenge (ASC24) finals are scheduled to take place at Shanghai University from... Read more.
Capcom’s Dragon’s Dogma 2 Sales Top 2.5 Million Units!
Dragon’s Dogma series cumulative sales now exceed 10 million units OSAKA, Japan–(BUSINESS WIRE)–#Capcom–Capcom Co., Ltd. (TOKYO:9697) today... Read more.
Wilson Partners Brings Barnbrook Sinclair Onboard, Strengthening Accounting Group’s Presence in South East England
LONDON–(BUSINESS WIRE)–High growth accounting, tax and corporate finance firm Wilson Partners has acquired the Woking-based firm Barnbrook Sinclair.... Read more.
Sparxell Raises $3.2m to Advance Development of Sustainable Pigments
CAMBRIDGE, U.K.–(BUSINESS WIRE)–Sparxell, the UK-based developer of high-performance, sustainable, plant-based pigments, has completed a $3.2m funding... Read more.
Informatica Launches Saudi Arabia’s First AI-Powered Intelligent Data Management Cloud Platform
Announcement supports Kingdom’s bold move to become a cloud-first, digitally empowered country, and furthers Saudi Arabia’s goal to become a Middle... Read more.
Merz Enters Asset Purchase Agreement With a US-Based Biotech Company
Second investment in a NASDAQ company in just over ten years. FRANKFURT AM MAIN, Germany–(BUSINESS WIRE)–Merz Therapeutics, a business of Frankfurt-based... Read more.
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Application based on results from the TROPION-Breast01 phase 3 trial Additional BLA under review in the U.S. for Daiichi Sankyo and AstraZeneca’s datopotamab... Read more.